Celcuity to Present at the 2021 San Antonio Breast Cancer Symposium
Celcuity Inc. (CELC)
Last celcuity inc. earnings: 3/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
celcuity.com/home/investors
Company Research
Source: Accesswire
MINNEAPOLIS, MN / ACCESSWIRE / December 2, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that an abstract has been accepted for poster presentation at the 2021 San Antonio Breast Cancer Symposium (SABCS), which is being held virtually and in-person from December 7-10, 2021.Poster presentation details are provided below.Title: "Phase 1b expansion study of gedatolisib in combination with palbociclib and endocrine therapy in women with ER+ advanced breast cancer"Presenter: Rachel M. Layman, MDPoster Discussion: Spotlight Poster Discussion 13Poster Session: Poster Session 5 - Hall 1Presentation Time: December 10, 2021, 7 - 8:30 a.m. CT (8 - 9:30 a.m. ET)The poster will be accessible on Celcuity's website at the same time.For more details about SABCS please visit: https://www.sabcs.org/.About CelcuityCelcuity is a clinical-stage biotechnology
Show less
Read more
Impact Snapshot
Event Time:
CELC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELC alerts
High impacting Celcuity Inc. news events
Weekly update
A roundup of the hottest topics
CELC
News
- Celcuity Inc. (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $24.00 price target on the stock.MarketBeat
- Celcuity To Present at Upcoming Needham and Stifel Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Celcuity To Present at Upcoming Needham and Stifel Investor ConferencesGlobeNewswire
- Celcuity Gains 12%, Insider Trades Reap Benefit [Yahoo! Finance]Yahoo! Finance
- Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
CELC
Earnings
- 3/27/24 - Beat
CELC
Sec Filings
- 4/10/24 - Form 4
- 3/29/24 - Form 8-K
- 3/29/24 - Form ARS
- CELC's page on the SEC website